Itron (NASDAQ:ITRI) Price Target Increased to $110.00 by Analysts at Stephens

Itron (NASDAQ:ITRIGet Free Report) had its price target increased by equities researchers at Stephens from $85.00 to $110.00 in a research report issued on Monday, Benzinga reports. The firm currently has an “equal weight” rating on the scientific and technical instruments company’s stock. Stephens’ price objective would indicate a potential upside of 3.02% from the company’s current price.

ITRI has been the subject of a number of other research reports. Canaccord Genuity Group upped their price objective on shares of Itron from $105.00 to $115.00 and gave the stock a “buy” rating in a research report on Friday. Canaccord Genuity Group raised shares of Itron from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $68.00 to $105.00 in a report on Tuesday, February 27th. TheStreet raised shares of Itron from a “c” rating to a “b-” rating in a research report on Monday, February 26th. Oppenheimer upped their target price on shares of Itron from $100.00 to $110.00 and gave the company an “outperform” rating in a research note on Friday. Finally, JPMorgan Chase & Co. increased their price objective on shares of Itron from $77.00 to $92.00 and gave the stock a “neutral” rating in a report on Wednesday, March 13th. Four equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. According to MarketBeat.com, Itron currently has an average rating of “Moderate Buy” and a consensus price target of $104.18.

View Our Latest Stock Analysis on Itron

Itron Stock Down 0.2 %

Shares of ITRI traded down $0.23 during trading hours on Monday, reaching $106.78. 93,266 shares of the stock traded hands, compared to its average volume of 431,440. The company has a market cap of $4.90 billion, a price-to-earnings ratio of 30.77, a PEG ratio of 1.16 and a beta of 1.38. The company has a current ratio of 1.90, a quick ratio of 1.40 and a debt-to-equity ratio of 0.33. Itron has a 52 week low of $56.11 and a 52 week high of $108.60. The stock has a fifty day simple moving average of $91.94 and a 200 day simple moving average of $77.64.

Itron (NASDAQ:ITRIGet Free Report) last announced its quarterly earnings results on Thursday, May 2nd. The scientific and technical instruments company reported $1.24 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.85 by $0.39. The company had revenue of $603.44 million for the quarter, compared to the consensus estimate of $579.49 million. Itron had a return on equity of 14.51% and a net margin of 7.03%. Itron’s revenue was up 22.0% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.49 EPS. On average, equities analysts forecast that Itron will post 3.68 EPS for the current year.

Insiders Place Their Bets

In other news, Director Jerome J. Lande sold 14,896 shares of the business’s stock in a transaction dated Thursday, March 7th. The shares were sold at an average price of $95.25, for a total value of $1,418,844.00. Following the completion of the sale, the director now owns 5,750 shares of the company’s stock, valued at approximately $547,687.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Itron news, CFO Joan S. Hooper sold 1,560 shares of Itron stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $75.37, for a total value of $117,577.20. Following the transaction, the chief financial officer now owns 60,141 shares of the company’s stock, valued at $4,532,827.17. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Jerome J. Lande sold 14,896 shares of the firm’s stock in a transaction on Thursday, March 7th. The shares were sold at an average price of $95.25, for a total transaction of $1,418,844.00. Following the completion of the transaction, the director now directly owns 5,750 shares of the company’s stock, valued at $547,687.50. The disclosure for this sale can be found here. In the last three months, insiders sold 30,467 shares of company stock valued at $2,752,520. Company insiders own 1.45% of the company’s stock.

Institutional Trading of Itron

Institutional investors have recently added to or reduced their stakes in the stock. Vanguard Group Inc. grew its stake in shares of Itron by 2.6% during the 3rd quarter. Vanguard Group Inc. now owns 5,668,071 shares of the scientific and technical instruments company’s stock worth $343,372,000 after acquiring an additional 142,564 shares during the period. Dimensional Fund Advisors LP boosted its stake in shares of Itron by 3.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 1,681,573 shares of the scientific and technical instruments company’s stock worth $126,978,000 after acquiring an additional 51,874 shares during the period. Vontobel Holding Ltd. raised its position in Itron by 16.0% during the fourth quarter. Vontobel Holding Ltd. now owns 804,648 shares of the scientific and technical instruments company’s stock valued at $60,759,000 after purchasing an additional 110,849 shares during the period. Guinness Asset Management LTD raised its holdings in shares of Itron by 1.9% in the third quarter. Guinness Asset Management LTD now owns 635,881 shares of the scientific and technical instruments company’s stock worth $38,504,000 after buying an additional 11,983 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its position in Itron by 3.0% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 518,157 shares of the scientific and technical instruments company’s stock valued at $39,126,000 after acquiring an additional 15,157 shares in the last quarter. 96.19% of the stock is currently owned by institutional investors.

Itron Company Profile

(Get Free Report)

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

Featured Articles

Analyst Recommendations for Itron (NASDAQ:ITRI)

Receive News & Ratings for Itron Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Itron and related companies with MarketBeat.com's FREE daily email newsletter.